Sodium Nitroprusside (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Sodium Nitroprusside drug offered from Sagent Pharmaceuticals. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | Sodium Nitroprusside |
| SUBSTANCE NAME: | SODIUM NITROPRUSSIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vasodilation [PE],Vasodilator [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-06 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Nitroprusside HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Nitroprusside from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2016-10-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-310_d500db35-05f1-4f03-aeb4-b3b04ef4e300 |
| PRODUCT NDC: | 25021-310 |
| APPLICATION NUMBER: | ANDA207426 |
Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers:
